Madhav V. Dhodapkar
Researcher Next ID · RN-023228
Researcher · Medicine
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Cape Town, South Africa
- Works count
- 450
- Citation count
- 24,817
- H-index
- 71
- i10-index
- 182
Research interests
Publications
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Journal of Clinical Oncology · 2025 · https://doi.org/10.1200/jco-24-01893
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Journal of Clinical Oncology · 2024 · https://doi.org/10.1200/jco.24.01008
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.01740
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.18.02096
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Journal for ImmunoTherapy of Cancer · 2018 · https://doi.org/10.1186/s40425-018-0460-5
Early B cell changes predict autoimmunity following combination immune checkpoint blockade
Journal of Clinical Investigation · 2018 · https://doi.org/10.1172/jci96798
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.65.9789
Combination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo
The Journal of Immunology · 2014 · https://doi.org/10.4049/jimmunol.1401686
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Science Translational Medicine · 2014 · https://doi.org/10.1126/scitranslmed.3008068
Classification of current anticancer immunotherapies
Oncotarget · 2014 · https://doi.org/10.18632/oncotarget.2998
International prognostic scoring system for Waldenström macroglobulinemia
Blood · 2009 · https://doi.org/10.1182/blood-2008-08-174961
Bortezomib enhances dendritic cell (DC)–mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications
Blood · 2007 · https://doi.org/10.1182/blood-2006-10-054221
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
Blood · 2006 · https://doi.org/10.1182/blood-2006-03-011353
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis
Blood · 2006 · https://doi.org/10.1182/blood-2006-07-037077
Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris
The Journal of Experimental Medicine · 2004 · https://doi.org/10.1084/jem.20030451
Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance
Annals of the New York Academy of Sciences · 2003 · https://doi.org/10.1111/j.1749-6632.2003.tb06029.x
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
Seminars in Oncology · 2003 · https://doi.org/10.1053/sonc.2003.50038
Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells
The Journal of Experimental Medicine · 2002 · https://doi.org/10.1084/jem.20011097
Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans
Blood · 2002 · https://doi.org/10.1182/blood.v100.1.174
Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells
The Journal of Experimental Medicine · 2001 · https://doi.org/10.1084/jem.193.2.233
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.
PubMed · 2001
Active immunization against cancer with dendritic cells: The near future
International Journal of Cancer · 2001 · https://doi.org/10.1002/ijc.1503
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
Journal of Clinical Investigation · 1999 · https://doi.org/10.1172/jci6909
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
New England Journal of Medicine · 1999 · https://doi.org/10.1056/nejm199911183412102
Current projects
No projects listed.